Difference between revisions of "Metoclopramide (Reglan)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "manufacturer. Instead" to "manufacturer. Instead") |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class/mechanism: Antiemetic; | + | Class/mechanism: Antiemetic; antiemetic action of metoclopramide is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ) |
<br>Route: PO/IV | <br>Route: PO/IV | ||
<br>Extravasation: unknown | <br>Extravasation: unknown | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information. |
==Diseases for which it is used== | ==Diseases for which it is used== | ||
''No known antineoplastic properties. Used for treatment and/or prevention of chemotherapy-induced nausea & vomiting.'' | ''No known antineoplastic properties. Used for treatment and/or prevention of chemotherapy-induced nausea & vomiting.'' | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Brand name:''' Reglan | ||
| + | |||
| + | [[Category:Drugs]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| Line 15: | Line 18: | ||
[[Category:Dopamine receptor antagonist]] | [[Category:Dopamine receptor antagonist]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1980]] |
[[Category:WHO Essential Pain and Palliative Care Medicine]] | [[Category:WHO Essential Pain and Palliative Care Medicine]] | ||
Latest revision as of 01:04, 29 June 2024
General information
Class/mechanism: Antiemetic; antiemetic action of metoclopramide is due to its antagonist activity at D2 receptors in the chemoreceptor trigger zone (CTZ)
Route: PO/IV
Extravasation: unknown
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used for treatment and/or prevention of chemotherapy-induced nausea & vomiting.
Also known as
- Brand name: Reglan